作者: Ding-Quan Qian , Jincong Zhuo , Meizhong Xu , Colin Zhang , Wenqing Yao
DOI:
关键词: Biology 、 Cancer 、 Kinase 、 Biochemistry
摘要: The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met useful in the treatment cancer other diseases related dysregulation kinase pathways.